Stereotactic Radiosurgery for AMD: A Monte Carlo-Based Assessment of Patient-Specific Tissue Doses

被引:17
作者
Hanlon, Justin
Firpo, Michael [3 ]
Chell, Erik [3 ]
Moshfeghi, Darius M. [4 ]
Bolch, Wesley E. [1 ,2 ]
机构
[1] Univ Florida, Dept Nucl & Radiol Engn, Adv Lab Radiat Dosimetry Studies ALRADS, Gainesville, FL 32611 USA
[2] Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA
[3] Oraya Therapeut Inc, Newark, CA USA
[4] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA
关键词
SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; PROTON-BEAM IRRADIATION; MACULAR DEGENERATION; RADIATION-THERAPY; PLAQUE RADIOTHERAPY; RANIBIZUMAB; DOSIMETRY; BRACHYTHERAPY; BEVACIZUMAB; TOLERANCE;
D O I
10.1167/iovs.10-6421
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To define the radiation doses to nontargeted ocular and adnexal tissues with Monte-Carlo simulation using a stereotactic low-voltage x-ray irradiation system for the treatment of wet age-related macular degeneration. METHODS. Thirty-two right/left eye models were created from three-dimensional reconstructions of 1-mm computed tomography images of the head and orbital region. The resultant geometric models were voxelized and imported to the MCNPX 2.5.0 radiation transport code for Monte Carlo-based simulations of AMD treatment. Clinically, treatment is delivered noninvasively by three divergent 100-kVp photon beams entering through the sclera and overlapping on the macula cumulating in a therapeutic dose. Tissue-averaged doses, localized point doses, and color-coded dose contour maps are reported from Monte Carlo simulations of x-ray energy deposition for several tissues of interest, including the lens, optic nerve, macula, brain, and orbital bone. RESULTS. For all eye models in this study (n = 32), tissues at risk did not receive tissue-averaged doses over the generally accepted thresholds for serious complication, specifically the formation of cataracts or radiation-induced optic neuropathy. Dose contour maps are included for three patients, each from separate groups defined by coherence to clinically realistic treatment setups. Doses to the brain and orbital bone were found to be insignificant. CONCLUSIONS. The computational assessment performed indicates that a previously established therapeutic dose can be delivered effectively to the macula with the scheme described so that the potential for complications to nontargeted radiosensitive tissues might be reduced. (Invest Ophthalmol Vis Sci. 2011;52:2334-2342) DOI: 10.1167/iovs.10-6421
引用
收藏
页码:2334 / 2342
页数:9
相关论文
共 40 条
[1]  
Adams J A, 1999, Med Dosim, V24, P233, DOI 10.1016/S0958-3947(99)00024-2
[2]   FLUORESCEIN ANGIOGRAPHIC FEATURES, NATURAL COURSE AND TREATMENT OF RADIATION RETINOPATHY [J].
AMOAKU, WMK ;
ARCHER, DB .
EYE, 1990, 4 :657-667
[3]  
[Anonymous], 1995, Ann ICRP, V25, P1
[4]  
[Anonymous], COCHRANE DATABASE SY
[5]  
[Anonymous], 2005, MCNPX user's manual version 2.5.0
[6]  
ARCHER D B, 1991, Eye (London), V5, P239
[7]  
Archer D B, 1994, Curr Opin Ophthalmol, V5, P59, DOI 10.1097/00055735-199406000-00011
[8]   Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration [J].
Avila, M. P. ;
Farah, M. E. ;
Santos, A. ;
Duprat, J. P. ;
Woodward, B. W. ;
Nau, J. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (03) :305-309
[9]   TWELVE-MONTH SAFETY AND VISUAL ACUITY RESULTS FROM A FEASIBILITY STUDY OF INTRAOCULAR, EPIRETINAL RADIATION THERAPY FOR THE TREATMENT OF SUBFOVEAL CNV SECONDARY TO AMD [J].
Avila, Marcos P. ;
Farah, Michel Eid ;
Santos, Arturo ;
Kapran, Ziya ;
Duprat, Joao Paulo ;
Woodward, Benjamin W. ;
Nau, Jeffrey .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (02) :157-169
[10]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444